The time course of new T-wave ECG descriptors following single- and double-dose administration of sotalol in healthy subjects

Ann Noninvasive Electrocardiol. 2010 Jan;15(1):26-35. doi: 10.1111/j.1542-474X.2009.00336.x.

Abstract

Introduction: The aim of the study was to assess the time course effect of IKr blockade on ECG biomarkers of ventricular repolarization and to evaluate the accuracy of a fully automatic approach for QT duration evaluation.

Methods: Twelve-lead digital ECG Holter was recorded in 38 healthy subjects (27 males, mean age = 27.4 + or - 8.0 years) on baseline conditions (day 0) and after administration of 160 mg (day 1) and 320 mg (day 2) of d-l sotalol. For each 24-hour period and each subject, ECGs were extracted every 10 minutes during the 4-hour period following drug dosage. Ventricular repolarization was characterized using three biomarker categories: conventional ECG time intervals, principal component analysis (PCA) analysis on the T wave, and fully automatic biomarkers computed from a mathematical model of the T wave.

Results: QT interval was significantly prolonged starting 1 hour 20 minutes after drug dosing with 160 mg and 1 hour 10 minutes after drug dosing with 320 mg. PCA ventricular repolarization parameters sotalol-induced changes were delayed (>3 hours). After sotalol dosing, the early phase of the T wave changed earlier than the late phase prolongation. Globally, the modeled surrogate QT paralleled manual QT changes. The duration of manual QT and automatic surrogate QT were strongly correlated (R(2) = 0.92, P < 0.001). The Bland and Altman plot revealed a nonstationary systematic bias (bias = 26.5 ms + or - 1.96*SD = 16 ms).

Conclusions: Changes in different ECG biomarkers of ventricular repolarization display different kinetics after administration of a potent potassium channel blocker. These differences need to be taken into account when designing ventricular repolarization ECG studies.

MeSH terms

  • Adult
  • Anti-Arrhythmia Agents / administration & dosage*
  • Anti-Arrhythmia Agents / blood
  • Biomarkers / blood
  • Dose-Response Relationship, Drug
  • Echocardiography, Three-Dimensional / methods
  • Echocardiography, Three-Dimensional / statistics & numerical data
  • Electrocardiography, Ambulatory / drug effects*
  • Electrocardiography, Ambulatory / methods
  • Electrocardiography, Ambulatory / statistics & numerical data*
  • Female
  • Heart Conduction System / drug effects*
  • Heart Rate / drug effects
  • Humans
  • Male
  • Normal Distribution
  • Principal Component Analysis / methods
  • Reference Values
  • Reproducibility of Results
  • Signal Processing, Computer-Assisted
  • Sotalol / administration & dosage*
  • Sotalol / blood
  • Time Factors
  • Vectorcardiography / methods
  • Vectorcardiography / statistics & numerical data

Substances

  • Anti-Arrhythmia Agents
  • Biomarkers
  • Sotalol